EGLN1 and neoplasm: A better understanding of the effect of hypoxic conditions early during tumour initiation and development, mimicked by PHD2 haplodeficiency, a situation readily present during chronic liver disease and tumour relapse, could allow us to pinpoint critical markers and events involved in the observed hypoxia induced phenotypic switch, therapy resistance and metastasis.